Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIg plus intravenous methylprednisolone for induction treatment in CIDP
NL-OMON21678Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic inflammatory demyelinating polyneuropathy (CIDP) comparing IVIg + methylprednisolone with IVIg + placebo (2 arms). Primary endpoint: Remission at 1 year. Started Feb 2019; status: recruiting.
02
Drugs
immune globulinmethylprednisolone
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on NL-OMON21678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21678.